These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3774112)

  • 1. Antinociceptive profile of sulfated CCK-8. Comparison with CCK-4, unsulfated CCK-8 and other neuropeptides.
    Barbaz BS; Autry WL; Ambrose FG; Hall NR; Liebman JM
    Neuropharmacology; 1986 Aug; 25(8):823-9. PubMed ID: 3774112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinociceptive action of cholecystokinin octapeptide (CCK 8) and related peptides in rats and mice: effects of naloxone and peptidase inhibitors.
    Hill RG; Hughes J; Pittaway KM
    Neuropharmacology; 1987 Apr; 26(4):289-300. PubMed ID: 3295578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unsulfated CCK-8 not blocked by proglumide or CR 1409 in the mouse abdominal irritant-induced stretching assay: possible central site of action.
    Ambrose FG; Barbaz BS; Autry WL; Browne RG; Liebman JM
    Peptides; 1989; 10(1):31-4. PubMed ID: 2748423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An investigation of the antinociceptive activity of calcitonin gene-related peptide alone and in combination with morphine: correlation to 45Ca++ uptake by synaptosomes.
    Welch SP; Cooper CW; Dewey WL
    J Pharmacol Exp Ther; 1988 Jan; 244(1):28-33. PubMed ID: 3257266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCK 8 analgesia and hyperalgesia after intrathecal administration in the rat: comparison with CCK-related peptides.
    Pittaway KM; Rodriguez RE; Hughes J; Hill RG
    Neuropeptides; 1987 Jul; 10(1):87-108. PubMed ID: 3670569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholecystokinin-A but not cholecystokinin-B receptor stimulation induces endogenous opioid-dependent antinociceptive effects in the hot plate test in mice.
    Derrien M; Noble F; Maldonado R; Roques BP
    Neurosci Lett; 1993 Oct; 160(2):193-6. PubMed ID: 8247353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation by thiorphan and bestatin of the naloxone-insensitive analgesic effects of neurotensin and neuromedin n.
    Coquerel A; Dubuc I; Kitaegi P; Costentin J
    Neurochem Int; 1988; 12(3):361-6. PubMed ID: 20501239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of endogenous cholecystokinin in the facilitation of mu-mediated antinociception by delta-opioid agonists.
    Noble F; Smadja C; Roques BP
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1127-34. PubMed ID: 7996417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinociceptive properties of a new tetrapeptide, Asn-Ala-Gly-Ala, in mice.
    Kosaka T; Sakurada S; Sakurada T; Sato T; Kisara K; Hosono M; Sasaki Y; Suzuki K
    Arch Int Pharmacodyn Ther; 1985 Oct; 277(2):280-8. PubMed ID: 4062439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indirect involvement of delta opioid receptors in cholecystokinin octapeptide-induced analgesia in mice.
    Hong EK; Takemori AE
    J Pharmacol Exp Ther; 1989 Nov; 251(2):594-8. PubMed ID: 2553928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of sulfated cholecystokinin octapeptide and proglumide injected intrathecally on antinociception induced by beta-endorphin and morphine administered intracerebroventricularly in mice.
    Suh HH; Tseng LF
    Eur J Pharmacol; 1990 Apr; 179(3):329-38. PubMed ID: 2142090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
    Ward SJ; Takemori AE
    J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analgesic responses elicited by endogenous enkephalins (protected by mixed peptidase inhibitors) in a variety of morphine-sensitive noxious tests.
    Schmidt C; Peyroux J; Noble F; Fournié-Zaluski MC; Roques BP
    Eur J Pharmacol; 1991 Jan; 192(2):253-62. PubMed ID: 2032557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antinociceptive effects of histidyl-proline diketopiperazine and thyrotropin-releasing hormone in the mouse.
    Kawamura S; Sakurada S; Sakurada T; Kisara K; Sasaki Y; Suzuki K
    Eur J Pharmacol; 1985 Jun; 112(3):287-94. PubMed ID: 3926517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential antagonism by proglumide of various CCK-mediated effects in mice.
    Barbaz BS; Autry WL; Ambrose FG; Gerber R; Liebman JM
    Prog Clin Biol Res; 1985; 192():151-8. PubMed ID: 4080708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of ciprofloxacin and gentamicin on spinal morphine-induced antinociception in rats.
    Luger TJ; Farkas W; Geisler H; Lorenz IH
    Basic Clin Pharmacol Toxicol; 2005 May; 96(5):366-74. PubMed ID: 15853929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinociceptive and antidepressant-like profiles of BL-2401, a novel enkephalinase inhibitor, in mice and rats.
    Kita A; Imano K; Seto Y; Yakuo I; Deguchi T; Nakamura H
    Jpn J Pharmacol; 1997 Dec; 75(4):337-46. PubMed ID: 9469639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological interaction between neuropeptides and pethidine or fentanyl in rat spinal cord.
    Herman ZS; Stachura Z
    Pol J Pharmacol; 1993; 45(5-6):481-92. PubMed ID: 7516784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholecystokinin B antagonists strongly potentiate antinociception mediated by endogenous enkephalins.
    Valverde O; Maldonado R; Fournie-Zaluski MC; Roques BP
    J Pharmacol Exp Ther; 1994 Jul; 270(1):77-88. PubMed ID: 8035345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the antinociceptive effects of a ganglioside derivative in rodents.
    Amico-Roxas M; Caruso A; Cioni M; Scifo R; Leone MG; Scapagnini U
    Arch Int Pharmacodyn Ther; 1988; 291():238-52. PubMed ID: 3259131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.